Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Oncocyte Corp
(NQ:
OCX
)
3.110
-0.100 (-3.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Oncocyte Corp
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 10, 2023
Via
Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
January 06, 2023
Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 06, 2023
The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
OncoCyte's Return On Capital Employed Insights
December 21, 2022
Via
Benzinga
Precision Diagnostics Company Oncocyte Cuts 40% Of Its Workforce
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 28, 2022
Via
Benzinga
GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
December 28, 2022
The Dow Jones settled slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 26, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Oncocyte Implements Cost Reduction Initiatives, Realigns Operations
August 11, 2022
Via
Benzinga
Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test
July 13, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Analyst Ratings for OncoCyte
December 01, 2022
Via
Benzinga
Expert Ratings for OncoCyte
December 01, 2022
Via
Benzinga
Expert Ratings for OncoCyte
May 12, 2022
Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings:
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 22, 2022
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 22, 2022
Good morning, investor! Let's get right into the biggest pre-market stock movers on Monday that traders will want to watch!
Via
InvestorPlace
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
August 22, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 18, 2022
Via
Benzinga
OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
August 18, 2022
The Dow Jones dropped by around 170 points on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Expert Ratings for OncoCyte
August 11, 2022
Over the past 3 months, 3 analysts have published their opinion on OncoCyte (NASDAQ:OCX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
May 24, 2022
Upgrades
Via
Benzinga
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023
May 19, 2022
Image by Nguyễn Hiệp on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
OncoCyte: Q1 Earnings Insights
May 11, 2022
OncoCyte (NASDAQ:OCX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings OncoCyte reported in-line EPS of...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.